Dr. Jill S. Waldman, MD

Dr. Waldman practices at Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System.

Dr. Waldman's NPI, 1386634129, was assigned on October 24, 2005. Dr. Waldman graduated from State University of New York Downstate Medical Center College of Medicine in 1991. Dr. Waldman holds New York license 189366.

Dr. Waldman's primary practice is Greenwich Hospital, at 5 Perryridge Rd, Greenwich, CT 06830 in Fairfield County. The practice phone is (203) 863-3000.

Dr. Waldman's primary practice is Greenwich Hospital in Greenwich, Connecticut, part of Yale New Haven Health System. Dr. Waldman is also affiliated with Yale New Haven Hospital. The medical group on file is Northeast Medical Group. Dmand AI also links Dr. Waldman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waldman practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Waldman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Waldman's licenses on file in 2 states: New York and Connecticut.

CMS data shows 454 Medicare services from Dr. Waldman across 6 procedure codes in 2024, for 284 Medicare patients. Medicare paid $37,984 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 284 Medicare patients who saw Dr. Waldman in 2024. The largest group is 85 and over, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Waldman's median patient age at 79, with 54% women.

In 2024, Dr. Waldman wrote 414 Medicare Part D claims for 156 patients. 85% of them were for generic drugs. CMS names the drug for 150 of them, across 8 drugs with 11 or more claims each, at $701 in total drug cost. In 2023, CMS named 157 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Waldman for performance year 2024, reported through an alternative payment model (APM). Dr. Waldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Dr. Waldman from 6 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $215.

Dr. Waldman graduated from State University of New York Downstate Medical Center College of Medicine in 1991.